Targets, interventions & cost-effectiveness
In his research project Job van Boven found that COPD patients who used their medication sub-optimally (non-adherent patients), were more often hospitalized, had lower quality of life and also decreased life expectation. In addition, total healthcare costs were higher and these patients showed higher work productivity losses. Individuals with a chronic lung disease, such as COPD, are dependent on the use of inhaled medication. These medications can substantially reduce dyspnea and prevent exacerbations. However, they are only optimally effective when used on a daily basis and with a correct inhalation technique (this is called “adherence”). The majority of patients have major difficulties in being or remaining adherent. Van Boven also discovered that side-effects are common after the start of new inhaled lung medication, especially in the first three months, but even after a year of use, they still occur. This is often related to incorrect inhalation technique. Obviously, we should not blame the COPD patients themselves for this. However, it highlights that physicians and pharmacists should spent more time on educating their patients on how to use their inhaled medication in a correct manner. Therefore, Van Boven subsequently investigated the effectiveness and cost-effectiveness of enhancing adherence, in The Netherlands as well as in Belgium. In both countries it appeared that patients that received extra education and instruction had fewer hospitalizations at lower total healthcare costs as compared to COPD patients receiving standard care. Van Boven concluded that optimizing medication adherence should therefore always be considered before starting new, often more expensive, therapies.
PhD ceremony: J.F.M. (Job) van Boven, MSc
When: September 25, 2015Start: 12:45Promotors: prof. dr. M.J. (Maarten) Postma, prof. dr. T. (Thys) van der Molen
Where: Academy building RUG
Faculty: Mathematics and Natural Sciences
Leonardo Arriagada Beltran conducted his PhD research on the interface of computer-generated art and the constantly evolving field of Artificial Intelligence (AI). He will defend his Phd thesis on 21 September. His research offers valuable insights...
Harish Vedantham and Casper van der Kooi have been nominated by New Scientist for Wetenschapstalent 2023 (Science Talent 2023). This election is meant to give young scientists and their research a stage.
No less than five promising PhD graduates from the University of Groningen will be able to conduct research at top institutes abroad for two years thanks to the Rubicon programme organized by the Netherlands Organisation for Scientific Research...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information